EDGAR Filing Documents for 0001193125-11-047354

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-11-047354

Filing Date

2011-02-25

Accepted

2011-02-25 15:53:38

Documents

Period of Report

2010-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1349436
2	AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY, DATED NOVEMBER 17, 2010	dex1057.htm	EX-10.57	18830
3	CONSENT OF PRICEWATERHOUSECOOPERS LLC	dex231.htm	EX-23.1	1808
4	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)	dex311.htm	EX-31.1	7725
5	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)	dex312.htm	EX-31.2	7837
6	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350	dex321.htm	EX-32.1	3713
7	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350	dex322.htm	EX-32.2	3718
8	GRAPHIC	g148267g47y05.jpg	GRAPHIC	50132
	Complete submission text file	0001193125-11-047354.txt		1463705

Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466

Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777

INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)